Jerusalem Daily Journal
SEE OTHER BRANDS

The latest news from Israel

Jerusalem Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jerusalem Daily Journal.

Press releases published on August 27, 2025

Conflow Power Group Limited Closes $20 Million Strategic License Agreement for its flagship product iLamp in Israel

Conflow Power Group Limited Closes $20 Million Strategic License Agreement for its flagship product iLamp in Israel

iLamp Israel Ltd איילמפ ישראל בע"מ is now fully operational as an exclusive license holder to distribute iLamp throughout Israel LONDON, UNITED KINGDOM, August 27, 2025 /⁨EINPresswire.com⁩/ -- London, England, Tel Aviv Israel – Conflow Power Group …

Cognata Launches DriveMatriX GenAI Data Augmentation on Azure NVads V710 v5, Accelerated by AMD Radeon PRO V710 GPUs

Cognata Launches DriveMatriX GenAI Data Augmentation on Azure NVads V710 v5, Accelerated by AMD Radeon PRO V710 GPUs

Cognata Launches DriveMatriX Supervised GenAI Data Augmentation Service on AMD NVads V710 v5 Accelerated by AMD Radeon™ PRO V710 GPUs on Microsoft Azure TEL AVIV, ISRAEL, August 27, 2025 /⁨EINPresswire.com⁩/ -- Cognata, a leader in AI-driven simulation …

ODYSIGHT.AI TO PARTICIPATE IN THE H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE

ODYSIGHT.AI TO PARTICIPATE IN THE H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE

OMER, Israel, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Odysight.AI Inc. (Nasdaq: ODYS), a leading developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), today announced that Einav Brenner, Chief Financial Officer, will …

Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

REHOVOT, Israel, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions